Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Lambert

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 15, 2014
Rationale for individualizing haemophilia careBenny Sørensen, Günter Auerswald, Gary Benson, et al.
British Journal of Haematology|December 11, 2002
Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodiesIsabelle Martin, Fayçal Kriaa, Valérie Proulle, et al.
The Journal of Antimicrobial Chemotherapy|June 23, 2016
High susceptibility of MDR and XDR Gram-negative pathogens to biphenyl-diacetylene-based difluoromethyl-allo-threonyl-hydroxamate LpxC inhibitorsMarie Titecat, Xiaofei Liang, Chul-Jin Lee, et al.
European Journal of Epidemiology|December 6, 2018
FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disordersAlexandra Doncarli, Virginie Demiguel, Irina Guseva Canu, et al.
Genome Biology and Evolution|October 15, 2014
The genomic diversification of the whole Acinetobacter genus: origins, mechanisms, and consequencesMarie Touchon, Jean Cury, Eun-Jeong Yoon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 19, 2023
Long-term immunogenicity, efficacy and tolerability of simoctocog alfa in patients with severe haemophilia A who had completed the NuProtect study in previously untreated patientsMary Mathias, Marina Abashidze, Aby Abraham, et al.
Blood Advances|August 8, 2022
Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studiesRebecca Kruse-Jarres, Flora Peyvandi, Johannes Oldenburg, et al.
BMJ Open|July 28, 2018
Determinants of adherence and consequences of the transition from adolescence to adulthood among young people with severe haemophilia (TRANSHEMO): study protocol for a multicentric French national observational cross-sectional studyNoémie Resseguier, Natacha Rosso-Delsemme, Any Beltran Anzola, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 15, 2014
Rationale for individualizing haemophilia careBenny Sørensen, Günter Auerswald, Gary Benson, et al.
British Journal of Haematology|December 11, 2002
Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodiesIsabelle Martin, Fayçal Kriaa, Valérie Proulle, et al.
The Journal of Antimicrobial Chemotherapy|June 23, 2016
High susceptibility of MDR and XDR Gram-negative pathogens to biphenyl-diacetylene-based difluoromethyl-allo-threonyl-hydroxamate LpxC inhibitorsMarie Titecat, Xiaofei Liang, Chul-Jin Lee, et al.
European Journal of Epidemiology|December 6, 2018
FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disordersAlexandra Doncarli, Virginie Demiguel, Irina Guseva Canu, et al.
Genome Biology and Evolution|October 15, 2014
The genomic diversification of the whole Acinetobacter genus: origins, mechanisms, and consequencesMarie Touchon, Jean Cury, Eun-Jeong Yoon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 19, 2023
Long-term immunogenicity, efficacy and tolerability of simoctocog alfa in patients with severe haemophilia A who had completed the NuProtect study in previously untreated patientsMary Mathias, Marina Abashidze, Aby Abraham, et al.
Blood Advances|August 8, 2022
Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studiesRebecca Kruse-Jarres, Flora Peyvandi, Johannes Oldenburg, et al.
BMJ Open|July 28, 2018
Determinants of adherence and consequences of the transition from adolescence to adulthood among young people with severe haemophilia (TRANSHEMO): study protocol for a multicentric French national observational cross-sectional studyNoémie Resseguier, Natacha Rosso-Delsemme, Any Beltran Anzola, et al.
Pageof 8